[Histonet] RE: her2 validation
JWeems <@t> sjha.org
Wed Mar 31 09:28:42 CDT 2010
>From June-15, 2009 CAP checklist
ANP.22997 Phase I N/A YES NO
If the laboratory performs HER2 testing (HER2 protein over-expression by immunohistochemistry [IHC] or HER2 gene amplification by in situ hybridization [e.g. FISH, CISH*, SISH*, etc.]), has the laboratory documented appropriate validation for the assay(s)?
NOTE: Initial test validation must be performed on a minimum of 25 cases (recommended 25-100). Validation may be performed by comparing the results of testing with a validated alternative method (i.e. IHC vs. FISH) either in the same laboratory or another laboratory, or with the same validated method performed in another laboratory; validation testing must be done using the same set of cases in both labs.
If specimens are fixed in a medium other than 10% neutral buffered formalin, the validation study must show that results are concordant with results from formalin-fixed tissues.
If significant changes are made in testing methods (e.g., antibody clone, antigen retrieval protocol or detection system, FISH probe or pretreatment protocol), revalidation is required.
This checklist item applies to laboratories that perform the technical testing of specimens for HER2 amplification. Patient specimens should be fixed in the same manner as the specimens used for the validation study(ies).
*CISH = chromogenic in-situ hybridization; SISH = silver-enhanced in-situ hybridization
Saint Joseph's Hospital
5665 Peachtree Dunwoody Rd NE
Atlanta, GA 30342
678-843-7376 - Phone
678-843-7831 - Fax
This email, including any attachments is the
property of Catholic Health East and is intended
for the sole use of the intended recipient(s).
It may contain information that is privileged and
confidential. Any unauthorized review, use,
disclosure, or distribution is prohibited. If you are
not the intended recipient, please reply to the
sender that you have received the message in
error, then delete this message.
More information about the Histonet